Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display (2023)
- Authors:
- USP affiliated authors: SETUBAL, JOÃO CARLOS - IQ ; CUNHA NETO, EDECIO - FM ; SABINO, ESTER CERDEIRA - FM ; GIORDANO, RICARDO JOSÉ - IQ ; MONTEIRO, JHONATAS SIRINO - CEBIMAR
- Unidades: IQ; FM; CEBIMAR
- DOI: 10.1371/journal.pntd.0011019
- Subjects: DOENÇA DE CHAGAS; GENOMAS; ANTICORPOS; TRYPANOSOMA CRUZI
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2023
- Source:
- Título: Plos Neglected Tropical Diseases
- ISSN: 1935-2735
- Volume/Número/Paginação/Ano: v. 17, n. 1, p. 1-20 art. e0011019, 2023
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CARNERO, Luis Antonio Rodriguez et al. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, v. 17, n. 1, p. 1-20 art. e0011019, 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0011019. Acesso em: 01 abr. 2026. -
APA
Carnero, L. A. R., Kuramoto, A., Oliveira, L. C. de, Monteiro, J. S., Setubal, J. C., Cunha Neto, E., et al. (2023). Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. Plos Neglected Tropical Diseases, 17( 1), 1-20 art. e0011019. doi:10.1371/journal.pntd.0011019 -
NLM
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1371/journal.pntd.0011019 -
Vancouver
Carnero LAR, Kuramoto A, Oliveira LC de, Monteiro JS, Setubal JC, Cunha Neto E, Sabino EC, Giordano RJ. Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display [Internet]. Plos Neglected Tropical Diseases. 2023 ; 17( 1): 1-20 art. e0011019.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1371/journal.pntd.0011019 - Recognition of Trypanosoma cruzi epitopes by IgG of benznidazole treated Chagas disease patients
- A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival
- A refined genome phage display methodology delineates the human antibody response in Chagas disease patients
- Inference and analysis of a gene regulatory network of angiogenesis in an oxygen-induced retinopathy mouse model
- Dynamic expression of Ralstonia solanacearum virulence factors and metabolism-controlling genes during plant infection
- The oxygen-induced retinopathy mouse model for drug discovery in angiogenesis
- Targeting transcription factors for antiangiogenic therapy
- Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease
- A Genome-Wide Association Study Identifies Novel Susceptibility loci in Chronic Chagas Cardiomyopathy
- Oxygen-induced pathological angiogenesis promotes intense lipid synthesis and remodeling in the retina
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3121058.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
